The market for allogeneic stem-cell transplants continues to grow. “We’re seeing an increased interest in allogeneic approaches and being able to have something readily available off the shelf,” said Joy Aho, senior product manager at Be The Match BioTherapies. The momentum of this growth is likely to continue for allogeneic therapies into 2022 as researchers…